Haemophilia trials in China

30 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Early phase 1Taking people
  A Study of FVIII Gene Therapy for Hemophilia A

  Where

  Tianjin

  Age

  18 years and over

  People

  8

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT05454774
• Phase 1Taking people
  Gene Therapy for Hemophilia B Patients Aged 12-18 Years Old

  Where

  Tianjin

  Age

  12 years to 18 years

  People

  9

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT05709288
• Early phase 1Taking people
  Safety and Efficacy Study of NGGT003 in Hemophilia A Patients

  Where

  Tianjin

  Age

  18 years and over

  People

  6

  Run by

  Institute of Hematology & Blood Diseases Hospital, China

  See details and how to joinNCT06238908
• No phaseTaking people
  Longitudinal Cohort of Thrombosis and Hemostasis Diseases

  Where

  Beijing, Chongqing, Zhengzhou

  People

  3,000

  Run by

  Peking University People's Hospital

  See details and how to joinNCT06727669
• Phase 3Not yet taking people in China
  Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A

  Where

  Chongqing, Guangzhou, Guizhou, Hangzhou, Hefei, Nanjing, Qingdao, Shenzhen, Taiyuan, Tianjing, Wuhan

  Age

  1 year to 12 years

  People

  76

  Run by

  Hangzhou Gensciences Biopharmaceutical Co., Ltd.

  See details and how to joinNCT06136507